Curaleaf Holdings Files 6-K, Sets Annual Meeting

Ticker: CURLF · Form: 6-K · Filed: 2025-05-19T00:00:00.000Z

Sentiment: neutral

Topics: 6-K, annual-meeting, corporate-governance

TL;DR

Curaleaf filed a 6-K on 5/19/25, confirming 40-F filing and announcing annual meeting.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on May 19, 2025, reporting for the month of May 2025. The filing indicates that Curaleaf will file its annual reports under Form 40-F. The report includes a Notice of Annual General Meeting as Exhibit 99.1.

Why It Matters

This filing provides an update on Curaleaf's reporting status and signals an upcoming annual general meeting, which is a routine corporate governance event.

Risk Assessment

Risk Level: low — This is a routine administrative filing and does not contain significant new financial or operational information.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

This Form 6-K is a report of a foreign private issuer filed for the month of May 2025, providing updates and including an Exhibit Index with a Notice of Annual General Meeting.

Which form does Curaleaf Holdings, Inc. use for its annual reports?

Curaleaf Holdings, Inc. indicates it files its annual reports under cover of Form 40-F.

Who signed this report on behalf of Curaleaf Holdings, Inc.?

The report was signed by Peter Clateman, Chief Legal Officer, on behalf of Curaleaf Holdings, Inc.

What is the principal executive office address listed for Curaleaf Holdings, Inc.?

The address of the Principal Executive Office is 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada.

What is the filing date of this report?

The filing date of this report is May 19, 2025.

From the Filing

0001756770-25-000018.txt : 20250519 0001756770-25-000018.hdr.sgml : 20250519 20250519170629 ACCESSION NUMBER: 0001756770-25-000018 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 86 CONFORMED PERIOD OF REPORT: 20250519 FILED AS OF DATE: 20250519 DATE AS OF CHANGE: 20250519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 25964966 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover051925.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: May 19, 2025 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Notice of Annual General Meeting of the Shareholders 99.2 Management Information Circular 99.3 Form of Proxy EX-99.1 2 curaleaf-notice.htm EX-99.1 curaleaf-notice CURALEAF HOLDINGS, INC. 290 Harbor Drive Stamford, CT 06902 NOTICE OF ANNUAL GENERAL MEETING OF THE SHAREHOLDERS NOTICE IS HEREBY GIVEN that the annual general meeting of shareholders (the “Meeting”) of Curaleaf Holdings, Inc. (the “Company”) will be held on June 13, 2025 at 9:00 a.m. (Eastern Time). This year again, the meeting will be held in a virtual format only. Our virtual annual general meeting of shareholders will allow all shareholders an equal opportunity to attend, vote and submit questions, no matter where they may physically be located on June 13, 2025. The Meeting will be held in virtual form only via live webcast at https://web.lumiconnect.com/262434694. The items for consideration at the Meeting are as follows: 1. to receive and consider the annual audited financial statements of the Company for the financial year ended December 31, 2024, together with the notes thereto and the auditors’ report thereon (the “Financial Statements”); 2. set the number of directors to ten (10) and elect as directors for the forthcoming year the nominees proposed by the Company (see page 16 of the accompanying management Circular (the “Information Circular”)); 3. to re-appoint PKF O’Connor Davies, LLP (“PKF O’Connor Davies”), as auditors of the Company and authorize the board of directors of the Company (the “Board”) to fix the auditors’ remuneration and terms of engagement (see page 27 of the Information Circular); and 4. to transact such other business as may properly come before the Meeting or any adjournment(s) or postponement(s) thereof. I would like to take this opportunity to extend, on behalf of the whole Board and Curaleaf team members, our gratitude to each of Mr. Peter Derby and Dr. Jaswinder Grover - who are not standing for re-

View on Read The Filing